insulin glulisine
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Pronunciation:
in-su-lin gloo-lye-seen

Trade Name(s)
- Apidra
- Apidra Solostar
Ther. Class.
Pharm. Class.
pancreatics
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Insulin Glulisine." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. The Washington Manual, www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51831/all/insulin_glulisine.
Vallerand AHA, Sanoski CAC, Quiring CC. Insulin glulisine. Davis's Drug Guide. F.A. Davis Company; 2023. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51831/all/insulin_glulisine. Accessed September 25, 2023.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Insulin glulisine. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51831/all/insulin_glulisine
Vallerand AHA, Sanoski CAC, Quiring CC. Insulin Glulisine [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2023 September 25]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51831/all/insulin_glulisine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - insulin glulisine
ID - 51831
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51831/all/insulin_glulisine
PB - F.A. Davis Company
ET - 18
DB - The Washington Manual
DP - Unbound Medicine
ER -